Advanced Therapies Integrates 2025

Bringing together industry leaders to drive the full potential of Advanced Therapies

02nd December 2025

EVENT TOPICS:

  • A Digital Revolution & A Person-Centric Approach

Advanced Therapies Integrates is dedicated to uniting industry leaders to drive and realize the full potential of Advanced Therapies and Medicinal Products (ATMPs). The event will focus on the key innovations within complex therapeutics, cell and gene therapies, regenerative medicines and tissue therapies and identify the challenges facing the industry, such as regulatory and commercial barriers to deploying transformational changes.

Uniquely engaging the broadest possible network, including innovators, regulators, supply chain partners, equipment and technology providers, academia, industry associations, and a wide array of government funding bodies and ATMP-focused initiatives, Advanced Therapies Integrates aims to become the leading UK event for translating cutting-edge research and disruptive innovation into widespread adoption of Advanced Therapies, delivering improved patient outcomes and revolutionizing healthcare economics.

Headline Sponsor

SPONSORS INCLUDE:

Pioneer Group Mills & Reeve Miltenyi Biotec Labman J A Kemp AscellaHealth

KEY SPEAKERS INCLUDE:

Register Now
Nicole Mather

Nicole Mather

IBM & Cell and Gene Therapy Catapult
Health Data, AI and Life Sciences Lead & Non Executive Director
Mustafa Munye

Mustafa Munye

Complement Therapeutics
Vice President Operations
Alessandra De Riva

Alessandra De Riva

Advent Bioservices
Head of Process Development and R&D
Simon Chandler

Simon Chandler

Rinri Therapeutics
Chief Executive Officer
Kerstin Papenfuss

Kerstin Papenfuss

Deep Science Ventures
Associate Director Therapeutics
Lucy Foley

Lucy Foley

eXmoor Pharma Concepts
Chief Technology Officer

AGENDA:

08:30 - 09:30
Registration and Networking
09:30 - 09:45
Opening Remarks
Miranda Knaggs
Facilitated by

Miranda Knaggs

Pioneer Group
Corporate Development Director

09:45 - 10:05
Fireside Chat
How is AI being used to accelerate and optimise cell therapy manufacturing processes today?
Nicole Mather

Nicole Mather

IBM & Cell and Gene Therapy Catapult
Health Data, AI and Life Sciences Lead & Non Executive Director

A Digital Revolution & A Person-Centric Approach

10:10 - 10:45

Making Collaboration Count

No one delivers advanced therapies alone. From shared manufacturing facilities to cross-sector clinical partnerships, collaboration is critical—but often easier said than done. This session dives into the practicalities of building partnerships that work: how are organisations aligning incentives, managing IP, and navigating competing priorities to accelerate progress?

PANELLISTS

  • Terri Gaskell | Rinri Therapeutics Ltd
  • Harry Kwong | Complement Therapeutics
  • Lucy Foley | eXmoor Pharma Concepts
  • Emily Howard | J A Kemp
  • James Fry | Mills & Reeve

10:45 - 11:15

Networking Coffee Break

11:15 - 11:50

In Their Shoes

Advanced therapies offer life-changing potential—but only if they reach the people who need them. As the sector moves toward broader adoption, how are we embedding patient perspectives early enough and deeply enough to design treatments that are truly fit for purpose? And what will it take to turn individual success stories into sustainable, population-level impact?

Facilitated by

Nicola Redfern

NJ Redfern Ltd
Consultant

11:55 - 12:30

Make Them Smarter

Digital technologies like automation, robotics and AI are no longer just on the horizon—they’re already being embedded into ATMP manufacturing. But what’s working, what’s not, and where are the real gains being made? This session explores how smart tools are being leveraged to overcome persistent challenges in product quality, scalability and consistency.

PANELLISTS

  • Antoine Espinet | MFX
  • Lindsay Fraser | Cytomos
  • Kwok Pang | adthera Bio
  • Alessandra De Riva | Advent Bioservices
  • Tom Smith | Labman Automation

12:30 – 13:30

Networking Lunch

13:30 - 14:05

Investment Realities

With public funding stretched and private capital more selective, where is the smart money going in 2026? This panel will explore how ATMPs are being evaluated in today’s climate. Are new business models emerging? How do we make the case for long-term health and economic returns—and what does a fundable ATMP look like now?

PANELLISTS

  • Simon Chandler | Rinri Therapeutics
  • Kerstin Papenfuss | Deep Science Ventures

14:10 - 14:45

Workforce in Progress

From cleanroom to clinic, the growth of advanced therapies is dependent on a highly-skilled workforce. As demand rises for specialised roles in R&D, GMP, and clinical delivery, how can the UK develop and retain the skills needed at scale? This session explores the realities of recruitment, training and talent development—and what it will take to futureproof the sector’s human infrastructure.

PANELLISTS

  • Anji Miller | LifeArc
  • Michael Baker | FUJIFILM Diosynth Biotechnologies

14:50 - 15:25

Start-Up Success in CGT

The CGT start-up journey is not for the faint-hearted. From tech transfer and team-building to navigating funding gaps and regulatory hurdles, what separates those who scale from those who stall? This session brings together founders, investors and enablers to unpack the realities of building a successful ATMP start-up—and what support the ecosystem needs to turn innovation into impact

Facilitated by

Marco Delise

Stevenage Bioscience Catalyst
Entrepreneurship and Business Development Director

PANELLISTS

  • Katy Newton | Achilles Therapeutics
  • Mustafa Munye | Complement Therapeutics
  • Abigail Martin | ImmuONE
  • David Venables | Laverock Therapeutics

15:25 – 16:25

Networking Drinks Reception

VENUE:

Victoria House, London

Victoria House, London

Victoria House, London

Victoria House, located in the heart of Bloomsbury, London, is a Grade II listed venue with state-of-the-art laboratories available for rent, designed to support scientific research and innovation. The laboratories are fully equipped with advanced technology and facilities, making them ideal for startups, established companies, and research institutions. In addition to labs, Victoria House also features flexible event spaces, advanced AV technology, and professional on-site support.

As part of the Pioneer Group, Victoria House is connected to Europe’s largest collective of scientists, technologists, and entrepreneurs. This dynamic environment supports collaboration with universities, high-growth enterprises, large corporates, healthcare providers, and local government. Pioneer Group offers a range of programmes, including Pre-Accelerator Workshops, Accelerator Programmes, and Launch support, to help businesses grow and innovate. Companies also benefit from expert networks, investment opportunities, and tailored events that foster a unique culture.

Address:

Victoria House

Bloomsbury Square, London WC1B 4DA, United Kingdom

Please click here to find us.

More Details

EVENT SPONSORS:

Life Science Integrates
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.